In a pilot sham-controlled crossover trial in 12 patients with drug-resistant epilepsy, low-intensity focused ultrasound did not significantly reduce seizure frequency vs sham (p=.068); seizures fell in the open-label extension; adverse events were transient and mild-moderate.
RCTn = 12
Chou et al. Low-intensity focused ultrasound neuromodulation for drug-resistant epilepsy: A randomized, sham-controlled crossover trial